Dr. Alexander Sinclair-Wilson is a Principal of Qiming Venture Partners, focusing on investments in the healthcare sector.
Alexander joined Qiming Venture Partners in 2024. Prior to joining Qiming, he worked at SV Health Investors and Sanofi Ventures, investing in and supporting biotherapeutic companies across different modalities, therapeutic areas and stages of development.
Alexander completed a PhD in Stem Cell Development at University College London and Yale University, and holds MSci and MA degrees in Natural Sciences from the University of Cambridge.
